Lumenis (LMNS) Earns Media Impact Rating of 0.50

Press coverage about Lumenis (NASDAQ:LMNS) has been trending positive on Friday, Accern Sentiment reports. Accern scores the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Lumenis earned a daily sentiment score of 0.50 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 45.9723814520318 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

TRADEMARK VIOLATION WARNING: “Lumenis (LMNS) Earns Media Impact Rating of 0.50” was first reported by Ticker Report and is the property of of Ticker Report. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.tickerreport.com/banking-finance/3355092/lumenis-lmns-earns-media-impact-rating-of-0-50.html.

Lumenis Company Profile

Lumenis Ltd. (Lumenis) is a provider of energy-based, minimally invasive clinical solutions. The Company operates through three segments: surgical, ophthalmic and aesthetic. The Company offers energy-based solutions for medically necessary and elective procedures, primarily for the aging population. Its solutions include the holmium laser, the Lumenis Pulse 120H, used for urologic applications; the VersaPulse PowerSuite platform which uses holmium lasers for urologic applications; the M22 multi-energy, a multi-application platform for the treatment of various skin conditions, and the Selecta multi-modality platform for retinal, secondary cataract and glaucoma therapies.

Insider Buying and Selling by Quarter for Lumenis (NASDAQ:LMNS)

Receive News & Ratings for Lumenis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lumenis and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Standex International  Earns Coverage Optimism Score of 0.03
Standex International Earns Coverage Optimism Score of 0.03
Tesla  PT Lowered to $376.00
Tesla PT Lowered to $376.00
Net 1 UEPS Technologies  Downgraded by BidaskClub
Net 1 UEPS Technologies Downgraded by BidaskClub
Zillow  Downgraded by Morgan Stanley
Zillow Downgraded by Morgan Stanley
Charter Financial  Sets New 12-Month High and Low at $22.68
Charter Financial Sets New 12-Month High and Low at $22.68
Viveve Medical  Receives New Coverage from Analysts at Stifel Nicolaus
Viveve Medical Receives New Coverage from Analysts at Stifel Nicolaus


Leave a Reply

© 2006-2018 Ticker Report. Google+.